Ownership history in Edgestream Partners, L.P. Β· 12 quarters on record
This page tracks every 13F SEC filing in which Edgestream Partners, L.P. reported a position in REPLIGEN CORP (RGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Edgestream Partners, L.P. underperformed the S&P 500 by β28.0% annually on this RGEN position. Timing score: 55% (6/11 decisions correct). Average cost basis: $184.20. Maximum drawdown during holding period: β57.0%.
β Significantly underperformed the S&P 500 by 28.0% ann.
11 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
6 of 11 add/trim decisions correct
Best entry: $124.38 (2025 Q2) Β· Worst: $288.99 (2021 Q3)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
7 adds Β· 5 trims. Bought during 4 of 7 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.04% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size